CDC funded disputed hepatitis B vaccine study, documents indicate
Records suggest funds nearing expiration pushed a hurried Danish vote on the study, whose researchers are based in Denmark.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
The CDC provided funding for a hepatitis B vaccine study that has drawn criticism. Experts have questioned the ethics of the research. Documents indicate that funds about to expire led to a hurried vote in Denmark, home to the researchers' institute.
Why it matters
Experts have raised ethical concerns about the study, and the rushed vote adds questions about how it was funded.
Timeline
- Oct 13, 8:00 PM ET: CDC funding for the hepatitis B vaccine study surfaces amid other vaccine policy disputes.
- Oct 14, 3:39 PM ET: Documents tie funds nearing expiration to a rushed Danish vote on the study.
Coverage
- How Controversial Hepatitis B Study Was Funded by CDC Amid Criticism (rollingstone.com)
- NIAID Nominee Nixed; CDC Funds Hep B Vax Study; 'Earth-Shaking' Vax Battle (medpagetoday.com)
More from Health
- Hackensack Meridian Health and Hunterdon Health agree to merge
- Roche signs $15 billion antibody-drug conjugate deal with Hansoh
- Putin's daughter predicts aging breakthroughs within 10 to 20 years
- Cardiologists urged to prescribe exercise for heart patients
- Pennsylvania measles outbreak tops 1,200 as CDC sends investigator
- AstraZeneca enlists Oracle to apply AI in drug trials